The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia

Annals of Tropical Medicine and Parasitology

Volumn 96, Issue 6, 2002, Pages 595-602

  Rajendran, R ^a   Sunish, I P ^a   Mani, T R ^a   Munirathinam, A ^a   Abdullah, S M ^a   Augustin, D J ^a   Satyanarayana, K ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; PARASITE ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FILARIASIS; FOLLOW UP; HUMAN; INDIA; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PREVALENCE; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTIGENS, HELMINTH; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIETHYLCARBAMAZINE; DRUG THERAPY, COMBINATION; FEMALE; FILARIASIS; FILARICIDES; FOLLOW-UP STUDIES; HUMANS; INDIA; MALE; PATIENT COMPLIANCE; PREVALENCE; TREATMENT OUTCOME; WUCHERERIA BANCROFTI;

NEMATODA; WUCHERERIA; WUCHERERIA BANCROFTI;

EID: 0036741467     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349802125001726     Document Type: Article

References (37)

1. Ananthakrishnan, S. & Das, P. K. (2001). Integrated programme for control of geohelminths: a perspective. National Medical Journal of India, 14, 148-153.
2. Beach, M. J., Streit, T. G., Addiss, D. G., Prospere, R., Roberts, J. M. & Lammie, P. J. (1999). Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. American Journal of Tropical Medicine and Hygiene, 60, 479-486.
3. Chanteau, S., Glaziou, P., Luquiaud, P., Plichart, C., Moulia-Pelat, J. P. & Cartel, J. L. (1994). Og4C3 circulating antigen, anti-Brugia malayi IgG and IgG4 titers in Wuchereria bancrofti infected patients, according to their parasitological status. Tropical Medicine and Parasitology, 45, 255-257.
4. Das, P. K. & Pani, S. P. (2000). Towards elimination of lymphatic filariasis in India: problems, challenges, opportunities and new initiatives. Journal of the International Medical Science Academy, 13, 18-26.
5. Das, P. K., Ramaiah, K. D., Augustin, D. J. & Kumar, A. (2001a). Towards elimination of lymphatic filariasis in India. Trends in Parasitology, 17, 457-460.
6. Das, P. K., Ramaiah, K. D., Vanamail, P., Pani, S.: P., Yuvaraj, J., Balaraman, K. & Bundy, D. A. (2001b). Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 336-341.
7. Day, K. P., Spark, R., Garner, P., Raiko, A., Wenger, J. D., Weiss, N., Mitchell, G. F., Alpers, M. P. & Kazura, J. W. (1991). Serological evaluation of the macrofilaricidal effects of diethylcarbamazine treatment in bancroftian filariasis. American Journal of Tropical Medicine and Hygiene, 44, 528-535.
8. Dreyer, G., Noroes, J., Addiss, D., Santos, A., Medeiros, Z. & Figueredo-Silva, J. (1999). Bancroftian filariasis in a paediatric population: an ultrasonographic study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 633-636.
9. Eberhard, M. L., Lammie, P. J., Dickinson, C. M. & Roberts, J. M. (1991). Evidence of non-susceptibility to diethylcarbamazine in Wuchereria bancrofti. Journal of Infectious Diseases, 163, 1157-1160.
10. Eberhard, M. L., Hightower, A. W., Addiss, D. G. & Lammie, P.J. (1997). Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. American Journal of Tropical Medicine and Hygiene, 57, 483-486.
11. Freedman, D. O., Plier, D. A., de Almeida, A. B., de Oliveira, A. L., Miranda, J. & Braga, C. (2001). Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Tropical Medicine and International Health, 6, 37-41.
12. Freeman, A. R., Lammie, P. J., Houston, R., Lapointe, M. D., Streit, G. T., Jooste, P. L., Brissau, J. M., Lafontant, J. G. & Addiss, D. G. (2001). A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine. American Journal of Tropical Medicine and Hygiene, 65, 865-871.
13. Ismail, M. M., Jayakody, R. L., Weil, G. J., Nirmalan, N., Jayasinghe, K. S., Abeyewickrema, W., Rezvi Sheriff, M. H., Rajaratnam, H. N., Amarasekera, N., de Silva, D. C., Michalski, M. L. & Dissanaike, A. S. (1998). Efficacy of single dose combination of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 94-97.
14. Ismail, M. M., Jayakody, R. L., Weil, G. J., Fernando, D., de Silva, M. S. G., de Silva, G. A. C. & Balasooriya, W. K. (2001). Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 332-335.
15. Jaoko, W. G., Simonsen, P. E., Meyrowitsch, D. W., Pedersen, E. M., Rwegoshora, R. T. & Michael, E. (2001). Wuchereria bancrofti in a community with seasonal transmission: stability of microfilaraemia, antigenaemia and filarial-specific antibody concentrations. Annals of Tropical Medicine and Parasitology, 95, 253-261.
16. Karam, M. & Ottesen, E. A. (2000). The control of lymphatic filariasis. Médecine Tropicale, 60, 291-296.
17. Lammie, P. J., Hightower, A. W. & Eberhard, M. L. (1994). Age specifc prevalence of antigenaemia in a Wuchereria bancrofti-exposed population. American Journal of Tropical Medicine and Hygiene, 51, 348-355.
18. Lammie, P. J., Reiss, M. D., Dimock, K. A., Streit, T. G., Roberts, J. M. & Eberhard, M. L. (1998). Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. American Journal of Tropical Medicine and Hygiene, 59, 217-221.
19. Mani, T. R., Rajendran, R., Munirathinam, A., Sunish, I. P., Abdullah, S. M., Augustin, D. J. & Satyanarayana. K. (2002). Efficacy of co-administration of albendazole and diethylcarbamazine on geohelminthiases: a study from South India. Tropical Medicine and International Health, 7, 541-548.
20. Nicolas, L. (1997). New tools for diagnosis and monitoring of bancroftian filariasis parasitism: the Polynesian experience. Parasitology Today, 13, 370-375.
21. Noroes, J., Dreyer, G., Santos, A., Mendes, V. G., Mendeiros, Z. & Addiss, D. (1997). Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 78-81.
22. Ottesen, E. A., Ismail, M. M. & Horton, J. (1999). The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitology Today, 15, 382-386.
23. Ramaiah, K. D., Das, P. K., Appavoo, N. C., Ramu, K., Augustin, D. J., Kumar, K. N. & Chandrakala, A. V. (2000). A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single dose DEC mass treatment and some related operational aspect. Tropical Medicine and International Health, 5, 842-847.
24. Ramaiah, K. D., Vijay Kumar, K. N., Chandrakala, A. V., Augustin, D. J., Appavoo, N. C. & Das, P. K. (2001). Effectiveness of community and health services-oriented drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Tropical Medicine and International Health, 6, 1062-1069.
25. Ravindran, B., Satapathy, K., Sahoo, P. K. & Babu Geddam, J. J. (2000). Protective immunity in human bancroftian filariasis: inverse relationship between antibodies to microfilarial sheath and circulating filarial antigens. Parasite Immunology, 22, 633-637.
26. Savioli, L., Crompton, D. W. T., Ottesen, E. A., Montresor, A. & Hayashi, S. (1997). Intestinal worms beware: developments in antihelmintic chemotherapy usage. Parasitology Today, 13, 43-44.
27. Simonsen, P. E., Lemnge, M. M., Msangeni, H. A., Jakobsen, P. H. & Bygbjerg, I. C. (1996). Bancroftian filariasis: the patterns of filarial-specific immunoglobulin G1 (IgG1), IgG4, and circulating antigens in an endemic community of northeastern Tanzania. American Journal of Tropical Medicine and Hygiene, 55, 69-75.
28. Steel, C., Ottesen, E. A, Weller, P. F. & Nutman, T. B. (2001). Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. American Journal of Tropical Medicine and Hygiene, 65, 498-503.
29. Stephenson, I. & Wiselka, M. (2000). Drug treatment of tropical parasitic infections: recent achievements and developments. Drugs, 60, 985-995.
30. Sunish, I. P., Rajendran, R., Satyanarayana, K., Munirathinam, A. & Gajanana, A. (2001). Immunochromatographic test (ICT) for estimation of true prevalence of bancroftian filariasis in an endemic area in southern India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 605-607.
31. Sunish, I. P., Rajendran, R., Mani, T. R., Munirathinam, A., Tewari, S. C., Hiriyan, J., Gajanana, A. & Satyanarayana, K. (2002). Resurgence in filarial transmission after withdrawal of mass drug administration and the inter-relationship between antigenaemia and microfilaraemia - a longitudinal study. Tropical Medicine and International Health, 7, 59-69.
32. Tisch, D. J., Hazlett, F. E., Kastens, W., Alpers, M. P., Bockarie, M. J. & Kazura, J. W. (2001). Ecologic and biologic determinants of filarial antigenaemia in bancroftian filariasis in Papua New Guinea. Journal of Infectious Diseases, 184, 898-904.
33. Turner, P. & Michael, E. (1997). Recent advances in the control of lymphatic filariasis. Parasitology Today, 13, 410-411.
34. Weil, G. J., Sethumadhavan, K. V., Santhanam, S., Jain, D. C. & Ghosh, T. K. (1988). Persistence of parasite antigenaemia following diethylcarbamazine therapy of bancroftian filariasis. American Journal of Tropical Medicine and Hygiene, 38, 589-595.
35. Witt, C. & Ottesen, E. A. (2001). Lymphatic filariasis: an infection of childhood. Tropical Medicine and International Health, 8, 582-606.
36. World Health Organization (1999). Collaborative Global Programme to Eliminate Lymphatic Filariasis: Programmes Background and Overview Towards Initiating a National Programme to Eliminate Lymphatic Filariasis. Document WHO/CEE/FIL. Geneva: WHO.
37. World Health Organization (2000). Eliminate Filariasis: Attack Poverty. The Global Alliance to Eliminate Lymphatic Filariasis. Proceedings of the First Meeting. Santigo de Compostela, Spain, 4-5 May 2000. Document WHO/CDS/CPE/CEE/2000.05. Geneva: WHO.